Share on

Latin America Infection Control Market Analysis Report – Segmented By Products and Services, End-User and Country (Brazil, Mexico, Argentina, Chile and Rest of Latin America) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2023 to 2028)

Published: March, 2023
ID: 11732
Pages: 90
Formats: report pdf report excel report power bi report ppt

Latin America Infection Control Market Size (2023 to 2028)

The Latin American infection control market is forecasted to grow at a CAGR of 13.37% from 2023 to 2028 and the market size is predicted to be worth USD 7.21 billion by 2028 from USD 3.85 billion in 2023.

The growing number of people suffering from hospital-acquired infections is one of the major factors increasing the need to take necessary precautions to control the infection spread, which is primarily driving the Latin America infection control market growth. HAIs are dangerous and may also lead to death in some cases. Around 5% to 10% of hospital-acquired infection cases result in death. The awareness around infection control is increasing among Latin American countries, which is expected to result in market growth during the forecast period. Programs such as the National Program of Epidemiology and Control of Hospital-Acquired Infections have been conducted in Argentina to reduce infections using infection control methods. This hospital-acquired infection is primarily seen in ICU rooms. Hospital-acquired infection can spread from patient to patient or healthcare worker.

The rising number of surgeries across the Latin American region further propels the infection control market growth in Latin America. The number of surgical procedures in Latin America is growing aggressively across the Latin American region owing to the growing prevalence of chronic and infectious diseases. The chance of being infected with the infection is high in the operating rooms. Patients who just had surgery have less immune power and are much more likely to get infections. The growing adoption of technological advancements in manufacturing sterilization equipment is anticipated to favor the market’s growth rate.

Growing usage of infection control services by pharmaceutical companies is anticipated to further promote the market’s growth rate. In addition, owing to increasing drug and vaccine manufacturing activities by pharmaceutical companies, people working in the companies may be affected by drug exposure for a long time if they are cleaned after a spell on the ground.

Owing to the growing aging population, the usage of infection control is anticipated to grow. Around 10% of the population in Latin America is now aging more than 60 years old. Older people are more prone to infectious diseases. Due to fewer antibodies and a weak immune system, older people need to take more care of infection control in their surroundings. In addition, early detection is more difficult in older adults.

However, high costs associated with infection control services and devices are one of the major factors hampering the infection control market growth in Latin America. In addition, side effects associated with infection control are inhibiting the growth of the infection control market in this region.

This research report on the Latin American infection control market has been segmented and sub-segmented into the following categories.

By Products and Services:

  • Cleaning and disinfection products
  • Sterilization products and services
  • Endoscope reprocessing products
  • Protective equipment
  • Others

By End-User:

  • Hospitals and clinics
  • Medical device companies
  • Pharmaceutical companies
  • Life sciences companies
  • Food Industry
  • Others

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

Geographically, countries such as Brazil, Mexico, and Argentina are expected to occupy most of the share in the Latin American infection control market during the forecast period. The factors driving the growth of the Argentinian infection control market are the accelerated economic growth of many countries, the increasing attention of the government in the health sector, the increase in the prevalence of chronic diseases, the COVID-19 epidemic, the investment of government agencies for the expansion of health care facilities and favorable regulatory reforms.

The Brazilian infection control market is expected to be another lucrative regional market in Latin America during the forecast period. Brazil was plagued by the burden of acute infections, affecting patients' safety. This has resulted in suffering, pain, delayed healing, increased use of antibiotics, revision surgery, increased length of hospital stays, morbidity, and mortality rates. It has also increased health spending. Therefore, institutional surveillance was implemented by the Brazilian Ministry of Health to meet the growing need to control nosocomial infections, and it has been practiced since then. In addition, the ministry has made it compulsory to set up an IAS control committee in public and private hospitals. These factors are driving the growth of the Brazilian infection control market.

KEY MARKET PLAYERS:

A few of the noteworthy companies operating in the Latin American infection control market profiled in this report are 3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample